{"id":12586,"date":"2016-07-18T15:46:13","date_gmt":"2016-07-18T15:46:13","guid":{"rendered":"https:\/\/www.heartgenetics.com\/oncoalvo\/"},"modified":"2016-07-18T15:46:13","modified_gmt":"2016-07-18T15:46:13","slug":"oncoalvo","status":"publish","type":"page","link":"https:\/\/www.heartgenetics.com\/pt\/sobre-nos\/financed-projects\/oncoalvo\/","title":{"rendered":"OncoAlvo"},"content":{"rendered":"<p><a href=\"https:\/\/www.heartgenetics.com\/wp-content\/uploads\/2017\/10\/banner-oncoalvo.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-4617 size-large\" src=\"https:\/\/www.heartgenetics.com\/wp-content\/uploads\/2017\/10\/banner-oncoalvo-1024x556.jpg\" alt=\"\" width=\"640\" height=\"348\" srcset=\"https:\/\/www.heartgenetics.com\/files\/uploads\/2017\/10\/banner-oncoalvo-1024x556.jpg 1024w, https:\/\/www.heartgenetics.com\/files\/uploads\/2017\/10\/banner-oncoalvo-600x326.jpg 600w, https:\/\/www.heartgenetics.com\/files\/uploads\/2017\/10\/banner-oncoalvo-300x163.jpg 300w, https:\/\/www.heartgenetics.com\/files\/uploads\/2017\/10\/banner-oncoalvo-768x417.jpg 768w, https:\/\/www.heartgenetics.com\/files\/uploads\/2017\/10\/banner-oncoalvo.jpg 1200w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/a><\/p>\n<p><a href=\"https:\/\/www.heartgenetics.com\/wp-content\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-3386\" src=\"https:\/\/www.heartgenetics.com\/wp-content\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom-300x45.png\" alt=\"pocentro_pt2020_feder_bom\" width=\"640\" height=\"96\" srcset=\"https:\/\/www.heartgenetics.com\/files\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom-300x45.png 300w, https:\/\/www.heartgenetics.com\/files\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom-600x91.png 600w, https:\/\/www.heartgenetics.com\/files\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom-768x116.png 768w, https:\/\/www.heartgenetics.com\/files\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom-1024x155.png 1024w, https:\/\/www.heartgenetics.com\/files\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom-150x23.png 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/a><\/p>\n<h2>OncoAlvo<\/h2>\n<p><a href=\"https:\/\/www.heartgenetics.com\/pt\/\">HeartGenetics<\/a>, in cooperation with<a href=\"http:\/\/www.ipoporto.pt\/\"> IPO Porto<\/a>, started developing research project OncoAlvo, a project focused on Optimizing Technological Innovations for Cancer Therapy Personalization, financed by program Portugal2020, Centro2020, in the amount of 467.815,86\u20ac, from European Regional Development Fund<\/p>\n<h2>Goals<\/h2>\n<ul>\n<li>Create a Research and Technology Development unit (IDT) related to cancer;<\/li>\n<li>Develop a new genetic diagnostic solution to support the definition of a personalized cancer therapy;<\/li>\n<li>Develop new cancer genetic diagnostic kit with CE-IVD marking.<\/li>\n<\/ul>\n<p><a href=\"https:\/\/www.heartgenetics.com\/pt\/\">HeartGenetics<\/a> would also like to see OncoAlvo\u2019s results translated in a significant decrease in the public investment in health and an increase in Portugal\u2019s notoriety amongst countries who are ahead in technological advances for cancer prevention.<\/p>\n<h2>Results<\/h2>\n<p>With the attainment of the proposed goals, OncoAlvo will provide a way to obtain a personalized and adequate therapy\/treatment which will allow observing an increase in life expectancy and life quality for each patient, ensuring the development of a more sustainable health policy, through a price reduction.<\/p>\n<p>&nbsp;<\/p>\n<hr \/>\n<p>&nbsp;<\/p>\n<p><a href=\"https:\/\/www.heartgenetics.com\/wp-content\/uploads\/2016\/07\/PT_flag.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-3213\" src=\"https:\/\/www.heartgenetics.com\/wp-content\/uploads\/2016\/07\/PT_flag.png\" alt=\"PT_flag\" width=\"41\" height=\"20\" \/><\/a><\/p>\n<p><a href=\"https:\/\/www.heartgenetics.com\/wp-content\/uploads\/2017\/10\/banner-oncoalvo.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-4617 size-large\" src=\"https:\/\/www.heartgenetics.com\/wp-content\/uploads\/2017\/10\/banner-oncoalvo-1024x556.jpg\" alt=\"\" width=\"640\" height=\"348\" srcset=\"https:\/\/www.heartgenetics.com\/files\/uploads\/2017\/10\/banner-oncoalvo-1024x556.jpg 1024w, https:\/\/www.heartgenetics.com\/files\/uploads\/2017\/10\/banner-oncoalvo-600x326.jpg 600w, https:\/\/www.heartgenetics.com\/files\/uploads\/2017\/10\/banner-oncoalvo-300x163.jpg 300w, https:\/\/www.heartgenetics.com\/files\/uploads\/2017\/10\/banner-oncoalvo-768x417.jpg 768w, https:\/\/www.heartgenetics.com\/files\/uploads\/2017\/10\/banner-oncoalvo.jpg 1200w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/a><\/p>\n<p><a href=\"https:\/\/www.heartgenetics.com\/wp-content\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom.png\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone wp-image-3386\" src=\"https:\/\/www.heartgenetics.com\/wp-content\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom-300x45.png\" alt=\"pocentro_pt2020_feder_bom\" width=\"640\" height=\"96\" srcset=\"https:\/\/www.heartgenetics.com\/files\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom-300x45.png 300w, https:\/\/www.heartgenetics.com\/files\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom-600x91.png 600w, https:\/\/www.heartgenetics.com\/files\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom-768x116.png 768w, https:\/\/www.heartgenetics.com\/files\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom-1024x155.png 1024w, https:\/\/www.heartgenetics.com\/files\/uploads\/2016\/07\/POCentro_PT2020_FEDER_Bom-150x23.png 150w\" sizes=\"auto, (max-width: 640px) 100vw, 640px\" \/><\/a><\/p>\n<p>A <a href=\"https:\/\/www.heartgenetics.com\/pt\/\">HeartGenetics<\/a>, em colabora\u00e7\u00e3o com o <a href=\"http:\/\/www.ipoporto.pt\/\">IPO Porto<\/a>, deu in\u00edcio ao desenvolvimento do \u00a0projeto de investiga\u00e7\u00e3o OncoAlvo, um projeto de Inova\u00e7\u00e3o Tecnol\u00f3gica Otimizada para a Personaliza\u00e7\u00e3o da Terapia Oncol\u00f3gica, financiado pelo programa Portugal 2020, no \u00e2mbito do programa Centro 2020 no montante de 467.815,86\u20ac, provenientes do Fundo Europeu de Desenvolvimento Regional.<\/p>\n<h2>Objetivos<\/h2>\n<ul>\n<li>Desenvolvimento de uma nova solu\u00e7\u00e3o de diagn\u00f3stico gen\u00e9tico para apoio \u00e0 defini\u00e7\u00e3o de uma terap\u00eautica oncol\u00f3gica personalizada;<\/li>\n<li>Cria\u00e7\u00e3o de uma unidade de Investiga\u00e7\u00e3o e Desenvolvimento Tecnol\u00f3gico na \u00e1rea da oncologia (IDT);<\/li>\n<li>Desenvolvimento de um novo KIT de diagn\u00f3stico gen\u00e9tico na \u00e1rea da oncologia com marca\u00e7\u00e3o CE-DIV.<\/li>\n<\/ul>\n<p>A <a href=\"https:\/\/www.heartgenetics.com\/pt\/\">HeartGenetics<\/a> considera ainda como meta ver os esfor\u00e7os e resultados do projeto de investiga\u00e7\u00e3o OncoAlvo refletidos numa diminui\u00e7\u00e3o do investimento p\u00fablico na \u00e1rea de sa\u00fade e num aumento da notoriedade de Portugal na lista de pa\u00edses que apresentam maiores avan\u00e7os tecnol\u00f3gicos na preven\u00e7\u00e3o de doen\u00e7as de foro oncol\u00f3gico.<\/p>\n<h2>Resultados<\/h2>\n<p>Com a obten\u00e7\u00e3o dos resultados delineados para este projeto ser\u00e1 poss\u00edvel obter uma terap\u00eautica personalizada e adequada permitindo aumentar a esperan\u00e7a e qualidade de vida de cada paciente, garantindo o desenvolvimento de uma pol\u00edtica de sa\u00fade mais sustent\u00e1vel, atrav\u00e9s da redu\u00e7\u00e3o de custos.<\/p>\n<p>&nbsp;<\/p>\n<p>&nbsp;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>OncoAlvo HeartGenetics, in cooperation with IPO Porto, started developing research project OncoAlvo, a project focused on Optimizing Technological Innovations for Cancer Therapy Personalization, financed by [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":0,"parent":12659,"menu_order":51,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"class_list":["post-12586","page","type-page","status-publish","hentry"],"acf":[],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/pages\/12586","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/comments?post=12586"}],"version-history":[{"count":0,"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/pages\/12586\/revisions"}],"up":[{"embeddable":true,"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/pages\/12659"}],"wp:attachment":[{"href":"https:\/\/www.heartgenetics.com\/pt\/wp-json\/wp\/v2\/media?parent=12586"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}